Meihua Medical Technologies Co., Ltd. (MHUA): Utang-utang marang kapitalisasi buku

Tandha merek meihuamed.com (MHUA)

Risks for MeihuaMed (MHUA) are tied to PRC government procurement and plastic prices. Low margins and stringent oversight pressure earnings, although the mass production of sterile products ensures supply stability. The current debt-to-book capitalization ratio demonstrates a support level, where 0.00 serves as the current parameter value, capturing the balance between borrowed funds and equity.

MHUA (Meihua Medical Technologies Co., Ltd.) riwayat Utang marang nilai buku saka 28.04.2023 nganti 20.12.2025
Produk asli Meihua Medical Technologies

MeihuaMed (MHUA) is expanding the production of medical devices for the B2B segment, which requires strict control over its financing structure. This indicator compares total borrowings with the book value of equity to assess financial stability. By analyzing the current ratio of debt to book equity, an investor determines the extent to which expansion depends on credit resources. A decrease in this metric indicates growing business autonomy, while a stable ratio confirms the long-term preservation of assets.

Karo sapa MeihuaMed saingan

ISRG - Utang-utang marang kapitalisasi buku|Rasio utang marang nilai buku danaher.com DHR|Utang-utang marang kapitalisasi buku BDX (Becton Dickinson)|STE - Utang-utang marang aset resik|WST (West Pharmaceutical Services Inc) - Utang-utang marang kapitalisasi buku|Baxter Healthcare (BAX) - Utang marang nilai buku|MASI (Masimo Corporation) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku STVN|Rasio utang marang kapitalisasi buku Teleflex (TFX)|Rasio utang marang kapitalisasi buku Merit Medical Systems, Inc. MMSI|Utang marang nilai buku Envista Holdings Corp|Rasio utang marang aset resik ICU Medical Inc. ICUI|Utang-utang marang kapitalisasi buku XRAY (DENTSPLY SIRONA Inc.)|LMAT: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku AtriCure|STAA (STAAR Surgical Co.) - Rasio utang marang nilai buku|NAGE: Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik ZimVie Corp (ZIMV)|Utang marang nilai buku AngioDynamics, Inc.|Utang marang modal buku CERS (cerus.com)|Rasio utang marang kapitalisasi buku Teknova|MGRM - Rasio utang marang aset resik|Sharps Tech - Utang marang nilai buku|INFU: Utang-utang marang kapitalisasi buku|UTMD (Utah Medical Products) - Rasio utang marang kapitalisasi buku|KORU Medical (KRMD) - Utang marang nilai buku|Utang-utang marang kapitalisasi buku NYXH (Nyxoah)|Utang-utang marang nilai buku MBOT|Rasio utang marang kapitalisasi buku Pro-Dex Corp PDEX|Rasio utang marang nilai buku Zentek Corp ZTEK|Utang marang nilai buku Elutia Inc. (ELUT)|milestonescientific.com - Utang marang modal buku|Rasio utang marang kapitalisasi buku NXGL (NEXGEL)|RVP: Utang-utang marang aset resik|HBIO (Harvard Bioscience, Inc.) - Rasio utang marang kapitalisasi buku|Femasys Corporation (FEMY) - Utang marang nilai buku|Utang-utang marang kapitalisasi buku POAI (Predictive Oncology Inc)|Utang-utang marang nilai buku Callan JMB Corp|ATRI (Atrion) - Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik NeuroMetrix Inc (NURO)